Gender difference in the pathophysiology and treatment of glaucoma

Shandiz Tehrani

Research output: Contribution to journalReview articlepeer-review

39 Scopus citations


Glaucoma is the principal cause of irreversible blindness in the world, the second leading cause of blindness in the United States, and it results in optic nerve head axonal degeneration and corresponding visual field deficits. Intraocular pressure (IOP) is the only known modifiable risk factor in glaucoma. Non-modifiable risk factors for glaucoma include age, ethnicity, central corneal thickness, and family history. While our understanding of the role of gender as a risk factor in glaucoma development and progression remains nascent, multiple observations have shown gender differences in the incidence and prevalence of glaucoma. Depending on the type of glaucoma, hormone therapy, oral contraceptive use and menopausal status have also been associated with glaucoma. In addition, pregnancy leads to changes in IOP, while the treatment of glaucoma must be tailored based on the systemic effects of topical therapeutics on the mother and fetus. This review will focus on the epidemiologic, anatomic and endocrinologic differences in male and female glaucoma patients. In addition, this review will discuss treatment modalities that may be more appropriate for one gender than the other, especially with respect to a woman's pregnancy status.

Original languageEnglish (US)
Pages (from-to)191-200
Number of pages10
JournalCurrent Eye Research
Issue number2
StatePublished - Feb 1 2015
Externally publishedYes


  • Gender
  • Glaucoma
  • Hormone therapy
  • Intraocular pressure
  • Pregnancy

ASJC Scopus subject areas

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience


Dive into the research topics of 'Gender difference in the pathophysiology and treatment of glaucoma'. Together they form a unique fingerprint.

Cite this